Mitochondrial Unfolded Protein Response (mtUPR)

•Pre-clinical— Strong worm/mouse data, limited human evidence

What it is

When mitochondrial proteostasis is disrupted, a retrograde signal is sent from the organelle to the nucleus to upregulate chaperones, proteases, and metabolic-adaptation genes inside the mitochondrion. In C. elegans this is mediated by ATFS-1; in mammals, primarily by ATF5 with contributions from ATF4 and CHOP. The output: HSP60, HSP10, LONP1, ClpP, and other mitochondrial chaperones and proteases.

Why it matters in aging

• mtUPR activation extends C. elegans lifespan ~40% in classic Houtkooper et al. work.
• Mitonuclear imbalance (e.g. mismatched ETC complex assembly) triggers mtUPR and improves healthspan in mice.
• Declining mtUPR capacity with age contributes to mitochondrial dysfunction.

Activators

• NAD⁺ precursors (NR/NMN).
• NQO1 / NRF2 activators (sulforaphane).
• Doxycycline / antibiotics at low doses (mitonuclear mismatch).
• Exercise — both endurance and resistance.
• Urolithin A — partly via mtUPR + mitophagy.

Pharmacology

No approved drugs target mtUPR directly. Several small molecules are in pre-clinical development for neurodegeneration and mitochondrial diseases.

More on this topic

• Calcium Signalling Dysregulation — Pathway.
• HSF1 / Heat-Shock Response — Pathway.
• GDF-15 — Biomarker.
• Mitobridge (acquired by Astellas) — Company.
• Stealth BioTherapeutics — Company.

Related entries

Mitochondrial dysfunction, Mitophagy, NAD+ precursors, Urolithin A.